Back to Search Start Over

Action Sites and Clinical Application of HIF-1α Inhibitors

Authors :
Renfeng Xu
Fan Wang
Hongqin Yang
Zhengchao Wang
Source :
Molecules, Vol 27, Iss 11, p 3426 (2022)
Publication Year :
2022
Publisher :
MDPI AG, 2022.

Abstract

Hypoxia-inducible factor-1α (HIF-1α) is widely distributed in human cells, and it can form different signaling pathways with various upstream and downstream proteins, mediate hypoxia signals, regulate cells to produce a series of compensatory responses to hypoxia, and play an important role in the physiological and pathological processes of the body, so it is a focus of biomedical research. In recent years, various types of HIF-1α inhibitors have been designed and synthesized and are expected to become a new class of drugs for the treatment of diseases such as tumors, leukemia, diabetes, and ischemic diseases. This article mainly reviews the structure and functional regulation of HIF-1α, the modes of action of HIF-1α inhibitors, and the application of HIF-1α inhibitors during the treatment of diseases.

Details

Language :
English
ISSN :
27113426 and 14203049
Volume :
27
Issue :
11
Database :
Directory of Open Access Journals
Journal :
Molecules
Publication Type :
Academic Journal
Accession number :
edsdoj.fac7ece2f6ae42c28b3bf9809ff69727
Document Type :
article
Full Text :
https://doi.org/10.3390/molecules27113426